FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?
Paradigm Biopharmaceuticals (ASX:PAR) has confirmed that it will use a twice weekly…
Paradigm Biopharmaceuticals Limited.. (ASX:PAR)
About Paradigm Biopharmaceuticals Limited..
Key Information
PAR In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 16/01/2025 | Notice of release of escrowed securities | 173KB | 1.0K |
| 30/12/2024 | Change of Director's Interest Notice | 49.74KB | 700 |
| 20/12/2024 | Notification regarding unquoted securities - PAR | 16.23KB | 577 |
| 13/12/2024 | Cleansing Notice | 132.72KB | 460 |
| 13/12/2024 | Application for quotation of securities - PAR | 15.46KB | 484 |
| 09/12/2024 | Price Sensitive PS PAR Capital Raising Presentation | 9.28MB | 39K |
| 09/12/2024 | Proposed issue of securities - PAR | 15.33KB | 497 |
| 09/12/2024 | Price Sensitive PS Successful Completion of $16M Placement for Phase 3 | 416.01KB | 38K |